Search
Build Back Better Act: Not Dead Yet
The $1.75 trillion Build Back Better Act has had a tough week and is on life support.
The Build Back Better Act Would Seriously Harm the Generic Drug Industry
Inside Sources: Biden and House Democrats are adopting policies that will harm pharmaceutical research and development.
President Biden Again Calls for Price Controls
President Biden's Monday speech included the same dangerous and wrong solutions to lower drug costs.
New Study Confirms 340B Program is Exploited
A new study, “340B and Health Equity: A Missed Opportunity in Medically Underserved Areas,” shows the program is misused.
The Republic is Safe, For Now
Congress has been on recess for a week, so the nation is safe from more prolific spending - for now.
Congress Should Listen to Voters and Reject Drug Price Controls
A message was sent by voters in Virginia, New Jersey, and New York last night. Is Congress listening?
Tobacco Harm Reduction Products Help Smokers Quit
It is discouraging to see governments around the world restrict access to THR products.
WHO Reopens Investigation into Origins of COVID-19 Virus
The World Health Organization reopens an investigation on origin of the corona virus; will China cooperate? What can Congress do?
CAGW Releases Issue Brief on the Dangers of Government-Run Healthcare
The brief details why a free market approach to healthcare reform is necessary.
President Biden is Raising Taxes for Those Earning Less Than 400K
Excise taxes on tobacco harm reduction products are irrational; it hurts both financially and those trying to quit smoking.
The CDC Has a Credibility Problem
CDC has had a reputation as the leading organization of its kind in the world, but has taken a big hit since COVID-19 arrived.
Committees Increase Taxes and Government Control of Healthcare in Budget Reconciliation
House committees have been busy these past few days, marking up their portion of the $3.5 trillion partisan reconciliation bill,